UPDATE: JPMorgan Starts Vera Therapeutics (VERA) at Overweight
Tweet Send to a Friend
(Updated - July 12, 2022 5:10 AM EDT)
JPMorgan analyst Anupam Rama initiates coverage on Vera Therapeutics (NASDAQ: VERA) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
JPMorgan analyst Anupam Rama initiates coverage on Vera Therapeutics (NASDAQ: VERA) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
